These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33675650)

  • 21. Pembrolizumab-induced cyclic ACTH-dependent Cushing's syndrome treated by a block-and-replace approach with osilodrostat.
    Paepegaey AC; Dot JM; Beauvy J; Juttet P; Le Berre JP
    Ann Endocrinol (Paris); 2022 Feb; 83(1):73-75. PubMed ID: 34871599
    [No Abstract]   [Full Text] [Related]  

  • 22. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
    Beauregard C; Dickstein G; Lacroix A
    Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease.
    Tanaka T; Satoh F; Ujihara M; Midorikawa S; Kaneko T; Takeda T; Suzuki A; Sato M; Shimatsu A
    Endocr J; 2020 Aug; 67(8):841-852. PubMed ID: 32378529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological treatment in adrenal Cushing's syndrome.].
    Stigliano A; Cerquetti L; Toscano V
    Recenti Prog Med; 2016 Nov; 107(11):574-581. PubMed ID: 27869874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole.
    Corcuff JB; Young J; Masquefa-Giraud P; Chanson P; Baudin E; Tabarin A
    Eur J Endocrinol; 2015 Apr; 172(4):473-81. PubMed ID: 25624013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological Treatment of Cushing's Syndrome.
    Castinetti F
    Arch Med Res; 2023 Dec; 54(8):102908. PubMed ID: 37977919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome.
    Valassi E; Crespo I; Gich I; Rodríguez J; Webb SM
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):735-42. PubMed ID: 22533782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological therapy of Cushing's syndrome: drugs and indications.
    Díez JJ; Iglesias P
    Mini Rev Med Chem; 2007 May; 7(5):467-80. PubMed ID: 17504182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome.
    Tabarin A; Navarranne A; Guérin J; Corcuff JB; Parneix M; Roger P
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):63-9. PubMed ID: 2004474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of diabetes mellitus in Cushing's syndrome.
    Munir A; Newell-Price J
    Neuroendocrinology; 2010; 92 Suppl 1():82-5. PubMed ID: 20829624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation and treatment of Cushing's syndrome.
    Nieman LK; Ilias I
    Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medical treatment for Cushing's syndrome].
    Nishikawa T; Saito J; Omura M
    Nihon Rinsho; 2008 Jan; 66(1):186-91. PubMed ID: 18186263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenally Directed Medical Therapies for Cushing Syndrome.
    Tritos NA
    J Clin Endocrinol Metab; 2021 Jan; 106(1):16-25. PubMed ID: 33118025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease.
    van den Bosch OF; Stades AM; Zelissen PM
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):184-90. PubMed ID: 23841642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review.
    Iwayama H; Hirase S; Nomura Y; Ito T; Morita H; Otake K; Okumura A; Takagi J
    BMC Endocr Disord; 2018 Mar; 18(1):19. PubMed ID: 29587720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of pharmacological options for Cushing's disease: what are the state-of-the-art options?
    Martino M; Aboud N; Lucchetti B; Salvio G; Arnaldi G
    Expert Opin Pharmacother; 2023 Apr; 24(5):557-576. PubMed ID: 36927238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cushing's disease: role of preoperative and primary medical therapy.
    Castinetti F
    Pituitary; 2022 Oct; 25(5):737-739. PubMed ID: 35780261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion.
    Sharma ST; Nieman LK
    Eur J Endocrinol; 2012 Mar; 166(3):531-6. PubMed ID: 22190002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?
    Ollivier M; Haissaguerre M; Ferriere A; Tabarin A
    Eur J Endocrinol; 2018 Oct; 179(5):L1-L2. PubMed ID: 30320504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.